Paganelli, G
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies. [electronic resource]
- Biopolymers 2002
- 393-8 p. digital
Publication Type: Journal Article
0006-3525
10.1002/bip.10349 doi
Humans
Neuroendocrine Tumors--drug therapy
Octreotide--adverse effects
Radiopharmaceuticals--adverse effects
Somatostatin--analogs & derivatives